Media Centre
Latest press releases
-
Full-year and Q4 2019 results
-
Brilinta met primary endpoint in Phase III THALES trial in stroke
-
AstraZeneca divests rights to established hypertension medicines
-
Phase II DESTINY-Gastric01 trial of Enhertu versus chemotherapy met primary endpoint
-
AstraZeneca to recover the global rights to brazikumab (MEDI2070) from Allergan
Medical Releases
These press releases are specifically for health specialist/medical media and are not for consumer press.
Contact us
Gonzalo Viña
Head of Global Media Relations
+44 203 749 5916
Rob Skelding
Director Global Media Relations (Oncology)
+44 203 749 5821
Rebecca Einhorn
Director Global Media Relations (Oncology)
+1 301 398 1802
Matthew Kent
Director Global Media Relations (BioPharmaceuticals)
+44 203 749 5906
Angela Fiorin
Director Global Media Relations (BioPharmaceuticals)
+44 122 334 4690
Jennifer Hursit
Manager Global Media Relations
+44 203 749 5762
Christina Malmberg Hägerstrand
Media Relations Director, Sweden and Nordic-Baltic
+46 855 253 106
